Celltrion Launches Autoimmune Disease Biosimilar Avtozma in U.S.
Seoul: Celltrion Inc., a leading South Korean biopharmaceutical company, announced the launch of its biosimilar Avtozma for treating autoimmune diseases in the United States. The
Seoul: Celltrion Inc., a leading South Korean biopharmaceutical company, announced the launch of its biosimilar Avtozma for treating autoimmune diseases in the United States. The
Seoul: The ruling Democratic Party (DP) and the main opposition People Power Party (PPP) have agreed to convene a plenary session of the National Assembly
Seoul: South Korean stocks opened sharply lower on Monday, amid renewed trade tensions between the United States and China. The benchmark Korea Composite Stock Price
Seoul: LG Electronics Inc., a prominent home appliance manufacturer based in South Korea, reported a significant decline in its third-quarter operating earnings, attributing the decrease
Seoul: Lewin Diaz of the Samsung Lions was named the top player in South Korean baseball for the final month of the regular season on
Seoul: South Korea has conveyed to the United States its determined intent to advance the modernization of their alliance, Foreign Minister Cho Hyun indicated on
The “Korean News Digest” website serves as a comprehensive hub for news, catering to an expansive range of categories including General, Business, Science, Fashion, Medical, Games, Governance, and Press Releases.
Â
The “Korean News Digest” website serves as a comprehensive hub for news, catering to an expansive range of categories including General, Business, Science, Fashion, Medical, Games, Governance, and Press Releases.
This diverse coverage showcases the site’s commitment to broad-spectrum news dissemination, aiming to engage a diverse audience with varied interests across multiple disciplines.